Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 November 2012: Diagnostics and Medical Technology  

Relationship of systemic blood pressure with ocular perfusion pressure and intraocular pressure of glaucoma patients in telemedical home monitoring

Clemens Jürgens BDFG , Rico Grossjohann CDE , Frank H.W. Tost ABDEFG

DOI: 10.12659/MSM.883529

Med Sci Monit 2012; 18(11): MT85-89

0 Comments

Background

In 2002 glaucoma jumped from third to second place on the list of the leading causes of blindness globally, which is published by the World Health Organization [1,2]. Glaucoma is becoming increasingly important in the context of an ageing world population. It poses a considerable challenge to public health, because blindness and visual impairment caused by glaucoma are irreversible. As a chronic eye disease glaucoma leads to a loss of retinal ganglion cells over the years, which results in characteristic optic nerve damage and typical visual field defects. In the early stages of glaucoma the patients affected may not realize that they are in danger of losing their sight, usually they only notice the few symptoms of the gradual loss of vision when retinal nerve fibres are already irreversibly lost. To avoid this feasible prevention, effective diagnostics and appropriate treatment are required, but this can only be achieved, if we improve our general understanding of glaucoma: “The medical understanding of the nature of glaucoma has changed profoundly in the past few years and a precise comprehensive definition and diagnostic criteria are yet to be finalised [3].”

Main risk factors for glaucoma development and progression are age and genetic predisposition, both parameters without interventional potential [4]. The only parameter subject to treatment is intraocular pressure, which is also correlated to glaucoma. However, this is insufficient because we observe both: individuals with elevated intraocular pressure without glaucomatous retinal changes (ocular hypertension) and individuals with normal intraocular pressure, who develop glaucoma (normal tension glaucoma). Furthermore, there are patients who develop glaucoma progression despite optimal treatment with successful intraocular depression [5–7]. The first evidence for the role of vascular components in the pathogenesis of primary open-angle glaucoma was reported in 1953 [8] and several studies have followed in the last few years [9–15]. In 1993 Kaiser et. al. demanded that blood pressure be considered in glaucoma treatment [16]. The impact of blood pressure and ocular perfusion pressure on glaucoma has received greater attention as evidence mounts [17].

Material and Methods

PATIENTS:

In the home monitoring project Teletonometry Mecklenburg-Vorpommern (TTMV) 153 probands were selected to evaluate the benefits of innovative telemedical glaucoma management. Eligible probands were individuals aged 18 years or older who had any type of glaucoma, ocular hypertension or suspected glaucoma. The main exclusion criteria were: blepharospasm, extreme visual impairment or blindness, diseases of the anterior segment, allergic inflammation, intraocular inflammation in the past six months or acute glaucoma. During the 12-month monitoring period 24 probands had to quit the study due to job-related or health-impaired factors (e.g. relocation, shift working or hospital admission due to accidents). The data presented in this study is exclusively based on the measured values of 70 patients with primary open-angle glaucoma. 33 patients were female, 37 were male. The average age of all 70 patients was 60.3±9.6 (mean ± SD). All participants were volunteers and gave their written consent to take part in this study. Local ethics committee approval was obtained to carry out this study.

STUDY DESIGN:

This study was designed as an observational study in two groups, conducted at the University Eye Hospital in Greifswald, Germany. Probands were recruited at the hospital itself, at ophthalmologic practices and through the media. They were randomly assigned in a 1:1 ratio to one of two groups. The first group underwent 6 months of telemedical home monitoring followed by 6 months conventional glaucoma management, whilst the second group started with 6 months conventional glaucoma management followed by 6 months of telemedical home monitoring. All probands were examined at the beginning, after 6 months and at the end of the study using all glaucoma relevant diagnostics.

STUDY ASSESSMENTS:

All patients were equipped with devices for telemedical home monitoring. For a period of 6 months they performed self-measurements of intraocular pressure and blood pressure at home and subsequently transmitted the data via a telemedical interface to a server in the hospital. The data was stored in electronic patient records, which were accessed by the ophthalmologists using a web frontend [18,19].

After extensive personal instruction in device handling the probands installed the devices at home and measured intraocular pressure with the Ocuton S (EPSa GmbH, Saalfeld, Germany), a self-tonometer using the Goldmann applanation principle, and blood pressure with the boso medicus PC (Bosch + Sohn GmbH u. Co. KG, Jungningen, Germany). We handed out a measuring schedule, that instructed the probands to check blood pressure and intraocular pressure in the morning and evening once a week and in addition to perform 24-hour profiles every 4 weeks. The majority of the probands decided to perform even more measurements than requested. The electronic patient record automatically calculated ocular perfusion pressure using the equation:

where:

STATISTICAL ANALYSIS:

The Kolmogorov-Smirnov and Shapiro-Wilk tests showed no normal distribution of the data, so we analyzed significance using the non-parametric Mann-Whitney and Waller-Duncan tests. All reported P values are two-sided. Statistical analysis was performed with the software SPSS.

Results

All 70 patients with primary open-angle glaucoma performed a total number of 3282 self-measurements at home and transmitted the data to the electronic patient record, which then calculated ocular perfusion pressure automatically from the submitted values. We analyzed intraday variations of ocular perfusion pressure and determined four characteristic phases: 7am – 12am, 12am – 6pm, 6pm – 10pm, 10pm – 7am [20]. Between 7am and 12am ocular perfusion pressure (Figure 1) and simultaneously systolic and diastolic blood pressure were significantly depressed (Figure 2) compared to all other phases (p<0.05) whereas intraocular pressure showed no significant shifting (Figure 3). Instead intraocular pressure was significantly depressed between 6pm and 10pm (p<0.05) where ocular perfusion pressure reached the highest intraday values (Figures 1, 3). Systolic blood pressure was significantly lowered from 7am – 12am (p<0.05) and significantly increased from 12am – 6pm (Figure 4).

Discussion

The vascular role in glaucoma pathophysiology has been studied intensely, but the etiology of primary open-angle glaucoma still remains unclear and relations between risk-factors appear to be controversial. Newer studies conclude that ocular perfusion pressure is strongly associated with glaucoma especially in persons with hypertension and hypertensive therapy [21]. Thus we have to reconsider the general impact of this diagnostic parameter as well as its relation to intraocular pressure. A recently published review provides a detailed and extensive overview of several milestone glaucoma studies [5]. The authors not only confirmed the role of ocular perfusion pressure as an important risk factor for the development and progression of glaucoma but furthermore pointed out that this parameter perfectly combines the vascular and mechanical components of glaucoma.

Since there is no feasible method to measure ocular perfusion pressure directly we investigated the approximated value calculated from home monitoring self-measurements of blood pressure and intraocular pressure. This framework demonstrated how easily ocular perfusion pressure can be obtained; nevertheless this important parameter has not yet been included continuously in large studies or clinical routine. Although self-tonometry is not yet common, we were able to observe several benefits for glaucoma patients: 24-hour profiles without hospital admission [22], completed diurnal documentation without office hours related gaps [22], optimized healthcare management for elderly patients in remote areas [23], positive health economics evaluation [24], and finally it opened new ways to analyze the relation of intraocular pressure, blood pressure and ocular perfusion pressure. The results of this study are not only important for ophthalmologists who still focus on intraocular pressure [4] and morphological or functional changes as treatment relevant parameters without regarding systemic blood pressure. We now have strong evidence that the glaucomatous effects of intraocular pressure depend on the characteristics of systemic blood pressure. In Figure 5 we present a clinical case report of a female patient, whose glaucoma medication was modified by her ophthalmologist while at the same time the general practitioner changed her hypertensive therapy, neither informed the other of the new treatment regime. They both regarded their intervention as successful because the patient’s intraocular pressure and blood pressure were lowered to appropriate levels. However both were unaware that as a result patient’s ocular perfusion pressure dropped under 45 mmHg, a level that increases the risk of glaucomatous damage progression [11,17]. This report illustrates that glaucoma is a systemic disease which requires interdisciplinary cross-sectional treatment. Consequently hypertensive therapy has to be adapted to ocular circulation in glaucoma patients to reduce the risk of morphologic damage. Our study has some limitations. Ocular perfusion pressure (OPP) was not measured directly instead it was calculated by taking mean arterial blood pressure and subtracting intraocular pressure (IOP). Since perfusion pressure is defined as the difference between arterial and venous pressure, and in the eye venous pressure is slightly higher than or even equal to IOP, for practical purposes the calculated OPP is a good approximation to quantify vascular changes [25,26]. Furthermore it was reported that the self-tonometer Ocuton S tended to over- or underestimate IOP compared to the gold standard Goldmann applanation tonometry (GAT) even though it uses the GAT principle to measure IOP [27,28]. However measurement accuracy of the self-tonometer was already improved after the implementation of a new firmware [29].

Conclusions

Our findings strengthen the evidence that blood pressure may contribute to optic disc damage in glaucoma patients. Still future research is needed to demonstrate how glaucoma patients may benefit from telemedical home monitoring in terms of slowing or even stopping morphological changes and glaucoma progression. Since glaucoma progresses slowly over several years this would require a long-lasting study setup. This would probably answer the question how strong perfusion pressure is as prognostic factor. Further efforts will have to be spent on improving the usability and reliability of the self-tonometer to advance measuring accuracy.

References

1. Resnikoff S, Pascolini D, Etya’ale D, Global data on visual impairment in the year 2002: Bull World Health Organ, 2004; 82; 844-51, pmid: 15640920

2. Kingman S, Glaucoma is second leading cause of blindness globally: Bull World Health Organ, 2004; 82; 887-88, pmid: 15640929

3. World Health Organization: Priority Eye Diseases: Glaucoma [WHO website] 1 3, 2011 http://www.who.int/blindness/causes/priority/en/index7.html

4. Kwon YH, Fingert JH, Kuehn MH, Alward WL, Primary open-angle glaucoma: N Engl J Med, 2009; 360; 1113-24, pmid: 19279343

5. Leibowitz HM, Krueger DE, Maunder LR, The Framingham Eye Study monograph. An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults. 1973–1975: Surv Ophthalmol, 1980; 24(Suppl); 335-610, pmid: 7444756

6. Quaranta L, Gandolfo F, Turano R, Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma: Invest Ophthalmol Vis Sci, 2006; 47; 2917-23, pmid: 16799034

7. Sommer A, Tielsch JM, Katz J, Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey: Arch Ophthalmol, 1991; 109; 1090-95, pmid: 1867550

8. Duke-Elder S, Primary glaucoma as a vascular disease; the James A. Craig prize lecture: Ulster Med J, 1953; 22; 3-16, pmid: 13078024

9. Hulsman CA, Vingerling JR, Hofman A, Blood pressure, arterial stiffness, and open-angle glaucoma: the Rotterdam study: Arch Ophthalmol, 2007; 125; 805-12, pmid: 17562992

10. Klein BE, Klein R, Knudtson MD, Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study: Br J Ophthalmol, 2005; 89; 284-87, pmid: 15722304

11. Leske MC, Wu SY, Hennis ABESs Study Group, Risk factors for incident open-angle glaucoma: the Barbados Eye Studies: Ophthalmology, 2008; 115; 85-93, pmid: 17629563

12. Orzalesi N, Rossetti L, Omboni SOPTIME Study Group (Osservatorio sulla Patologia glaucomatosa, Indagine Medico Epidemiologica); CONPROSO (Collegio Nazionale dei Professori Ordinari di Scienze Oftalmologiche), Vascular risk factors in glaucoma: the results of a national survey: Graefes Arch Clin Exp Ophthalmol, 2007; 245; 795-802, pmid: 17120006

13. Suzuki Y, Iwase A, Araie MTajimi Study Group, Risk factors for open-angle glaucoma in a Japanese population: the Tajimi Study: Ophthalmology, 2006; 113; 1613-17, pmid: 16828504

14. Topouzis F, Coleman AL, Harris A, Association of blood pressure status with the optic disk structure in non-glaucoma subjects: the Thessaloniki Eye Study: Am J Ophthalmol, 2006; 142; 60-67, pmid: 16815251

15. Xu L, Wang H, Wang Y, Jonas JB, Intraocular pressure correlated with arterial blood pressure: the Beijing eye study: Am J Ophthalmol, 2007; 144; 461-62, pmid: 17765433

16. Kaiser HJ, Flammer J, Graf T, Stümpfig D, Systemic blood pressure in glaucoma patients: Graefes Arch Clin Exp Ophthalmol, 1993; 231; 677-80, pmid: 8299973

17. Costa VP, Arcieri ES, Harris A, Blood Pressure and Glaucoma: Br J Ophthalmol, 2009; 93; 1276-82, pmid: 19336425

18. Jürgens C, Grossjohann R, Meiering J, Home-monitoring in ophthalmology-prerequisites for an improvement in quality of life: conclusions from the management research study Teletonometry Mecklenburg-Vorpommern: Klin Monatsbl Augenheilkd, 2009; 226; 459-65, pmid: 19507098

19. Jürgens C, Antal S, Heydenreich F, Digital patient record for remote monitoring of intraocular pressure, blood pressure and serum glucose: Klin Monatsbl Augenheilkd, 2006; 223; 757-64, pmid: 16986087

20. Antal S, Jürgens C, Grossjohann R, Tost FH, Diurnal variation of ocular pressure in open-angle glaucoma with telemonitoring: Klin Monatsbl Augenheilkd, 2009; 226; 168-75, pmid: 19294587

21. Leske MC, Heijl A, Hyman LEMGT Group, Predictors of long-term progression in the Early Manifest Glaucoma Trial: Ophthalmology, 2007; 114; 1965-72, pmid: 17628686

22. Jürgens C, Antal S, Henrici K, Fluctuation of intraocular pressure in 24-hour telemonitoring compared to tonometry during normal office hours: Klin Monatsbl Augenheilkd, 2009; 226; 54-59, pmid: 19173164

23. Jürgens C, Tost F, Progress in geriatric care through telemedicine: Ophthalmologe, 2006; 103; 749-54, pmid: 16924448

24. Swierk T, Jürgens C, Grossjohann R, Health economical aspects of telemedical glaucoma monitoring: Ophthalmologe, 2011; 108; 342-50, pmid: 21505968

25. Hayreh SS, The blood supply of the optic nerve head and the evaluation of it: myth and reality: Prog Retin Eye Res, 2001; 20; 563-93, pmid: 11470451

26. Hayreh SS, Blood flow in the optic nerve head and factors that may influence it: Prog Retin Eye Res, 2001; 20; 595-624, pmid: 11470452

27. Kóthy P, Nagymihály A, Holló G, The evaluation of tonometry and self-tonometry with Ocuton tonometers: Med Sci Monit, 2003; 9(1); PI1-4, pmid: 12552251

28. Marchini G, Babighian S, Specchia L, Perfetti S, Evaluation of the new Ocuton S tonometer: Acta Ophthalmol Scand, 2002; 80; 167-71, pmid: 11952483

29. Lanfermann E, Jürgens C, Grossjohann R, Intraocular pressure measurements with the newly reconfigured Ocuton S*TT-MV self-tonometer in comparison to Goldmann applanation tonometry in glaucoma patients: Med Sci Monit, 2009; 15(11); CR556-62, pmid: 19865054

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750